Dr. Barry Silberg invented the device used for external ultrasound assisted liposuction. His work with ultrasound, together with Dr. Seth Putterman, Professor of Physics at UCLA, expanded to the use of the device to disperse antibiotics into local tissues. It’s common practice to use a penicillin-based antibiotic called methicillin to treat these infections, but the overuse of antibiotics has resulted in resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA). Along with his colleague Dr. David Nicolau, Director of the Hartford Center for Anti-Infective Research and Development, Dr. Silberg has discovered Cefazolin, a commonly used antibiotic can be used to treat the most resistant strains of MRSA when delivered by this new method.
This PDF contains the study, including details about this new treatment, which involves an injection beneath the skin followed by an external ultrasound that delivers high concentrations of cefazolin (an antibiotic) to an area that requires treatment. This study is one of the many ways in which Dr. Silberg prioritizes patient care and stays at the forefront of medical technology. It can be read in its entirety here.